Citadel Advisors’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.9M | Sell |
25,100
-31,800
| -56% | -$2.39M | ﹤0.01% | 6171 |
|
|
2025
Q4 | $4.24M | Sell |
56,900
-182,100
| -76% | -$13.3M | ﹤0.01% | 4545 |
|
|
2025
Q3 | $16.1M | Buy |
239,000
+67,500
| +39% | +$4.48M | ﹤0.01% | 2602 |
|
|
2025
Q2 | $11.2M | Buy |
171,500
+136,300
| +387% | +$8.17M | ﹤0.01% | 2875 |
|
|
2025
Q1 | $2.17M | Sell |
35,200
-69,700
| -66% | -$4.62M | ﹤0.01% | 5369 |
|
|
2024
Q4 | $7.56M | Buy |
104,900
+63,700
| +155% | +$4.98M | ﹤0.01% | 3338 |
|
|
2024
Q3 | $3.36M | Buy |
41,200
+33,600
| +442% | +$2.69M | ﹤0.01% | 4601 |
|
|
2024
Q2 | $564K | Sell |
7,600
-23,500
| -76% | -$1.76M | ﹤0.01% | 7815 |
|
|
2024
Q1 | $2.42M | Sell |
31,100
-71,200
| -70% | -$5.3M | ﹤0.01% | 5155 |
|
|
2023
Q4 | $7.31M | Buy |
102,300
+51,100
| +100% | +$3.56M | ﹤0.01% | 3257 |
|
|
2023
Q3 | $3.55M | Buy |
51,200
+9,400
| +22% | +$710K | ﹤0.01% | 4193 |
|
|
2023
Q2 | $3.38M | Sell |
41,800
-2,600
| -6% | -$212K | ﹤0.01% | 4255 |
|
|
2023
Q1 | $3.58M | Sell |
44,400
-36,400
| -45% | -$2.93M | ﹤0.01% | 4359 |
|
|
2022
Q4 | $6.04M | Buy |
80,800
+18,200
| +29% | +$1.3M | ﹤0.01% | 3556 |
|
|
2022
Q3 | $4.04M | Sell |
62,600
-13,800
| -18% | -$956K | ﹤0.01% | 4237 |
|
|
2022
Q2 | $5.29M | Buy |
76,400
+30,000
| +65% | +$2.23M | ﹤0.01% | 3691 |
|
|
2022
Q1 | $3.56M | Buy |
46,400
+10,900
| +31% | +$784K | ﹤0.01% | 4837 |
|
|
2021
Q4 | $2.72M | Buy |
35,500
+1,600
| +5% | +$118K | ﹤0.01% | 5531 |
|
|
2021
Q3 | $2.5M | Sell |
33,900
-5,900
| -15% | -$442K | ﹤0.01% | 5803 |
|
|
2021
Q2 | $2.65M | Sell |
39,800
-17,600
| -31% | -$1.18M | ﹤0.01% | 5900 |
|
|
2021
Q1 | $4.27M | Buy |
57,400
+35,200
| +159% | +$2.67M | ﹤0.01% | 4619 |
|
|
2020
Q4 | $1.62M | Buy |
22,200
+8,500
| +62% | +$600K | ﹤0.01% | 5827 |
|
|
2020
Q3 | $911K | Sell |
13,700
-29,200
| -68% | -$1.85M | ﹤0.01% | 6207 |
|
|
2020
Q2 | $2.44M | Buy |
42,900
+3,900
| +10% | +$191K | ﹤0.01% | 4206 |
|
|
2020
Q1 | $1.37M | Sell |
39,000
-2,600
| -6% | -$124K | ﹤0.01% | 4779 |
|
|
2019
Q4 | $2.17M | Sell |
41,600
-5,100
| -11% | -$254K | ﹤0.01% | 4278 |
|
|
2019
Q3 | $2.36M | Buy |
46,700
+41,200
| +749% | +$2.03M | ﹤0.01% | 4224 |
|
|
2019
Q2 | $264K | Sell |
5,500
-29,500
| -84% | -$1.36M | ﹤0.01% | 7779 |
|
|
2019
Q1 | $1.69M | Sell |
35,000
-5,300
| -13% | -$239K | ﹤0.01% | 4737 |
|
|
2018
Q4 | $1.66M | Buy |
40,300
+11,300
| +39% | +$464K | ﹤0.01% | 4447 |
|
|
2018
Q3 | $1.19M | Buy |
29,000
+4,700
| +19% | +$190K | ﹤0.01% | 5248 |
|
|
2018
Q2 | $966K | Sell |
24,300
-7,200
| -23% | -$277K | ﹤0.01% | 5278 |
|
|
2018
Q1 | $1.18M | Buy |
31,500
+11,000
| +54% | +$444K | ﹤0.01% | 4555 |
|
|
2017
Q4 | $876K | Buy |
20,500
+2,600
| +15% | +$104K | ﹤0.01% | 4840 |
|
|
2017
Q3 | $657K | Buy |
17,900
+8,100
| +83% | +$327K | ﹤0.01% | 4932 |
|
|
2017
Q2 | $445K | Buy |
9,800
+1,100
| +13% | +$48.6K | ﹤0.01% | 5285 |
|
|
2017
Q1 | $370K | Sell |
8,700
-1,200
| -12% | -$48.9K | ﹤0.01% | 5544 |
|
|
2016
Q4 | $397K | Sell |
9,900
-4,100
| -29% | -$158K | ﹤0.01% | 5265 |
|
|
2016
Q3 | $544K | Buy |
14,000
+600
| +4% | +$22.6K | ﹤0.01% | 4733 |
|
|
2016
Q2 | $464K | Sell |
13,400
-2,800
| -17% | -$97K | ﹤0.01% | 4586 |
|
|
2016
Q1 | $559K | Sell |
16,200
-25,200
| -61% | -$879K | ﹤0.01% | 4256 |
|
|
2015
Q4 | $1.6M | Sell |
41,400
-24,300
| -37% | -$945K | ﹤0.01% | 2995 |
|
|
2015
Q3 | $2.57M | Buy |
65,700
+36,400
| +124% | +$1.44M | ﹤0.01% | 2637 |
|
|
2015
Q2 | $1.11M | Buy |
29,300
+9,000
| +44% | +$315K | ﹤0.01% | 3813 |
|
|
2015
Q1 | $670K | Sell |
20,300
-10,600
| -34% | -$325K | ﹤0.01% | 4492 |
|
|
2014
Q4 | $826K | Buy |
30,900
+3,500
| +13% | +$90.3K | ﹤0.01% | 4008 |
|
|
2014
Q3 | $667K | Buy |
27,400
+14,100
| +106% | +$356K | ﹤0.01% | 4236 |
|
|
2014
Q2 | $337K | Sell |
13,300
-400
| -3% | -$9.35K | ﹤0.01% | 4901 |
|
|
2014
Q1 | $295K | Sell |
13,700
-42,300
| -76% | -$913K | ﹤0.01% | 5044 |
|
|
2013
Q4 | $1.25M | Buy |
56,000
+40,300
| +257% | +$889K | ﹤0.01% | 3003 |
|
|
2013
Q3 | $324K | Sell |
15,700
-13,300
| -46% | -$283K | ﹤0.01% | 4270 |
|
|
2013
Q2 | $560K | Buy |
+29,000
| New | +$606K | ﹤0.01% | 3725 |
|
Other funds holding HOLX
VCM
HI
VPM
Citadel Advisors's HOLX Position: Q1 2026 in Review
Citadel Advisors increased its Hologic (HOLX) stake by 71% in Q1 2026, buying an estimated $34M and bringing the position to 1,090,660 shares worth $82.4M. The position accounts for 0.01% of the portfolio, ranked #947.
Citadel Advisors first reported a position in HOLX in Q2 2013 and has held it in 47 quarters since. The position peaked at $434M in Q3 2023. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.
- Citadel Advisors held 1,090,660 shares of Hologic worth $82.4M as of Q1 2026.
- Citadel Advisors bought 452,018 Hologic shares in Q1 2026, an estimated $34M.
- Hologic made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #947 holding.
- Citadel Advisors first reported a position in Hologic in Q2 2013 and has held it in 47 quarters since.
- Citadel Advisors's Hologic position peaked at $434M in Q3 2023.
- 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.